Tag: Cancer: Prostate
Osteoporosis Meds Up BMD in Nonmetastatic Prostate Cancer
Review shows improved bone mineral density in men receiving androgen deprivation therapy
Infection Is Most Common Complication of Prostate Biopsy
Fluoroquinolone-resistant E. coli plays prominent role in infection; rates range from 0.1 to 7.0 percent
Vascular Targeted Photodynamic Tx Aids Low-Risk Prostate Cancer
Achieves an 82 percent rate of absent clinically significant cancer in treated lobes
Study Supports Observation Only for Most Low-Risk Prostate CA
20-year study found little difference in mortality rates, more complications with surgery
Tall, Obese Men at Higher Risk of Aggressive Prostate Cancer
Study found taller, heavier males were more likely to develop prostate cancer, die from it
Decisional Regret Doesn’t Differ by Treatment in Prostate Cancer
Only African-American race was associated with greater regret across time
Germline Mutations Up in Men With Prostate CA, One Other CA
However, most of these men do not meet current clinical criteria for germline testing
Dutasteride Associated With Metabolic Safety Concerns
Use of medication in BPH linked to higher hemoglobin A1c and LDL cholesterol levels
Novel Biomarkers Identified for Prostate Cancer in Non-Blacks
PCA3 and T2ERG add utility for predicting prostate cancer when combined with PCPT risk calculator
ASCO: Abiraterone Extends Survival in Metastatic Prostate CA
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
